Original assessment ยท live

SSD: Hold

Published 21 Sep 2026, 03:03 BST. This is the frozen version, not the current recommendation.

Target$207.24
Target date2027-09-16
Price known at publication$171.232026-09-18

Why this assessment was issued

Stored financial statements changed; the revised figures need checking. The model version changed. Required data is available again; reconsider the suspended assessment. The published model version has been replaced. Record the new calculation basis even if the rating is unchanged. Neither a positive nor a negative classification meets the stated requirements. Review business evidence.

Neither a positive nor a negative classification meets the stated requirements. Review business evidence.

Supporting evidence

Year-to-date profit has improved

Across 2 completed quarters since 2025-12-31, net income was 215.3m versus 181.4m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.

More sales are becoming operating profit

The latest quarterly operating margin was 25.2%, +3.0 percentage points from a year earlier. Compare the sales and margin contributions below.

Opposing evidence

The starting valuation is below the price

The central assumptions give $123.36 per share, -28.0% against the weekly close. This is a scenario to test, not an analyst price target.

Borrowing is higher relative to earnings

Net debt / EBITDA: -0.0ร— for SSD, against -0.4ร— across 4 comparable peers.

The original scenarios

ScenarioSales growthProfit marginModel value
Weaker1.3%14.1%$158.34
Central6.3%15.7%$207.24
Stronger11.3%17.3%$265.14

Method: Earnings and historical valuation. A sufficiently complete, positive earnings record allows the stock's own P/E history to be used. These scenarios are not probability intervals.

Original assumptions and checks
eps8.89
cash450526000.0
debt423761000.0
years1.212867898699521
growth6.267256618642614
margin15.645415289991568
profit378916000.0
cash_okTrue
debt_okTrue
growths[6.192593753246589, 4.235556955640285, 9.105484370795791, 6.341919484038638]
revenue2421898000.0
downside7.530605277653146
leverage-0.04465812714510012
multiple21.55976331360947
free_cash468370000.0
buy_hurdle15
volatility28.93131082268584
history_end2026-09-18
reward_risk2.792818933214326
annual_years5
usable_weeks157
history_start2023-09-22
history_weeks157
financial_date2026-06-30
interest_coverNot available
operating_cash574364000.0
uncapped_growth6.267256618642614
current_multiple19.260967379077613
projected_margin15.714514550855515
historical_margin15.78361381171946

Recent price ยท Passed. Weekly close dated 2026-09-18.

Suitable business model ยท Passed. Value operating cash flow or comparable earnings; deduct debt and other ownership claims where appropriate.

Four quarters ยท Passed. Four quarters ending 2026-06-30.

Current financials ยท Passed. Statements through 2026-06-30; factor prices dated 2026-09-11.

Annual record ยท Passed. 5 consecutive annual profit margins, including loss years.

Comparable earnings history ยท Passed. P/E is usable in 157 of 157 weeks. At least 52 usable weeks and 70% coverage are required; excluding too many loss or missing weeks would bias the target.

Earnings and price dates ยท Passed. Earnings-release EPS $8.89, for four quarters ending 2026-06-30.

Price risk ยท Passed. Risk uses the latest 52 weekly price changes.

Comparable sales growth ยท Passed. Growth uses the median of four quarterly year-on-year comparisons.

Positive statement earnings ยท Passed. Trailing statement profit is positive.

Earnings reconciliation ยท Passed. Release EPS is $8.89; statement-derived EPS is $9.25. The difference is within the 5% review threshold; this does not prove there are no unusual items.

Statement totals ยท Passed. The latest four quarters agree with the trailing snapshot within 5%.

Cash and borrowing ยท Passed. Cash generation, debt and interest-cover figures are available.

Target publication review ยท Passed. The model estimate is within SM's automatic publication range of one quarter to four times the current price. This is a review threshold, not evidence that the market price is correct.

Policy sm-review-2-research ยท Model sm-assessment-14-operating-capital ยท Data 19210e50e6d4.

Open current research โ†—

Evidence context